In silico discovery of novel Retinoic Acid Receptor agonist structures

BMC Structural Biology

Volumn 1, Issue , 2001, Pages 1-7

  Schapira, Matthieu ^a   Raaka, Bruce M ^a   Samuels, Herbert H ^a   Abagyan, Ruben ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; ANTINEOPLASTIC AGENT; RETINOIC ACID RECEPTOR AGONIST; UNCLASSIFIED DRUG; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA;

ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DRUG STRUCTURE; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; ALGORITHM; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG POTENTIATION; METABOLISM;

RUMEX;

ALGORITHMS; ANTINEOPLASTIC AGENTS; BINDING SITES; MODELS, MOLECULAR; RECEPTORS, RETINOIC ACID;

EID: 3042782458     PISSN: 14726807     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-6807-1-1     Document Type: Article

References (29)

1. Fitzgerald P, Teng M, Chandraratna RA, Heyman RA, Allegretto EA: Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status. Cancer Res. 1997, 57:2642-2645
2. Fanjul AN, Piedrafita FJ, Al-Shamma H, Pfahl M: Apoptosis induction and potent antiestrogen receptor-negative breast cancer activity in vivo by a retinoid antagonist. Cancer Res. 1998, 58:4607-4610
3. Lu XP, Fanjul A, Picard N, Shroot B, Pfahl MA: Selective retinoid with high activity against an androgen-resistant prostate cancer cell type. Int. J. Cancer 1999, 80:272-278
4. Sun SY, Yue P, Dawson MI, Shroot B, Michel S, Lamph WW, Heyman RA, Teng M, Chandraratna RA, Shudo K, Hong WK, Lotan R: Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res. 1997, 57:4931-4939
5. Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, Hong WK, Lotan R: Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells. Cancer Res. 1999, 59:2829-2833
6. Mologni L, Ponzanelli I, Bresciani F, Sardiello G, Bergamaschi D, Gianni M, Reichert U, Rambaldi A, Terao M, Garattini E: The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases. Blood 1999, 93:1045-1061
7. Chandaratna RA: Future trends: a new generation of retinoids. J. Am. Acad. Dermatol. 1998, 39(4 Pt 2):S149-S152
8. Schapira M, Raaka B, Samuels HH, Abagyan R: Rational discovery of nuclear receptor antagonists. Proc. Natl. Acad. Sci. U S A 2000, 97:1008-1013
9. Lippman SM, Benner SE, Hong WK: Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis. Cancer Res. 1994, 54:2025s-2028s
10. Costa A, De Palo G, Decensi A, Formelli F, Chiesa F, Nava M, Camerini T, Marubini E, Veronesi U: Retinoids in cancer chemoprevention clinical trials with the synthetic analogue fenretinide. Ann. N. Y. Acad. Sci. 1995, 768:148-162
11. Liu Y, Lee MO, Wang HG, Li Y, Hashimoto Y, Klaus M, Reed JC, Zhang X: Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell. Biol. 1996, 16:1138-1149
12. Widschwendter M, Berger J, Daxenbichler G, Muller-Holzner E, Widschwendter A, Mayr A, Marth C, Zeimet AG: Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res. 1997, 57:4158-4161
13. Li Y, Dawson MI, Agadir A, Lee MO, Long L, Hobbs PD, Zhang XK: Regulation of RAR-β expression by RAR- and RXR-selective retinoids in human lung cancer cell lines: effect on growth inhibition and apoptosis induction. Int. J. Cancer 1998, 75:88-95
14. Xu XC, Liu X, Tahara E, Lippman SM, Lotan R: Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res. 1999, 59:2477-2483
15. Lin B, Chen G, Xiao D, Kolluri SK, Cao X, Su H, Zhang XK: Orphan receptor COUP-TF is required for induction of retinoic acid receptor beta growth inhibition and apoptosis by retinoic acid in cancer cells. Mol. Cell. Biol. 2000, 20:957-970
16. Sun SY, Wan H, Yue P, Hong WK, Lotan R: Evidence that retinoic acid receptor beta induction by retinoids is important for tumor cell growth inhibition J. Biol. Chem. 2000, 275:17149-17153
17. Molsoft LLC: ICM 2.7 Program Manual 1998
18. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D: Crystal structure of the (RAR-)g ligand-binding domain bound to all-trans retinoic acid. Nature 1995, 378:681-689
19. Delescluse C, Cavey MT, Martin B, Bernard BA, Reichert U, Maignan J, Darmon M, Shroot B: Selective high affinity retinoic acid receptor alpha or beta-gamma ligands. Mol. Pharmacol. 1991, 40:556-562
20. Totrov M, Abagyan R: Derivation of sensitive discrimination potential for virtual ligand screening. Proceedings of the 3rd annual international conference on computational molecular biology (RECOMB 99) Lyon France, ACM Press 1999 312-317
21. Schapira M, Totrov M, Abagyan R: Prediction of the binding energy for small molecules peptides and proteins. J. Mol. Recognit. 1999, 12:177-190
22. Qi JS, Desai-Yajnik V, Greene ME, Raaka BM, Samuels HH: The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization gene silencing and transactivation. Mol. Cell. Biol. 1995, 15:1817-1825
23. Li D, Desai-Yajnik V, Lo E, Schapira M, Abagyan R, Samuels HH: NRIF3 is a novel coactivator mediating functional specificity of nuclear hormone receptors. Mol. Cell. Biol. 1999, 19:7191-7202
24. Ogiso Y, Kitagawa K, Nishino H, Iwashima A, Shudo K: Suppression of c-mos expression in teratocarcinoma cells with a new type of inducer of differentiation 35-di-tert-butylchalcone 4′-carboxylic acid. Exp. Cell. Res. 1987, 173:262-266
25. Oikawa T, Hirotani K, Nakamura O, Shudo K, Hiragun A, Iwaguchi T: A highly potent antiangiogenic activity of retinoids. Cancer Lett. 1989, 48:157-162
26. Abagyan RA: Protein structure prediction by global energy optimization Computer Simulation of Biomolecular Systems. In: Theoretical and Experimental Applications Volume 3 (Edited by van Gunsteren WF et al.) Leiden, ESCOM Science Publishers BV 1997
27. Totrov M, Abagyan R: Flexible protein-ligand docking by global energy optimization in internal coordinates. Proteins 1997, Suppl 1:215-220
28. Abagyan R, Totrov M: Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. J. Mol. Biol. 1994, 235:983-1002
29. Abagyan RA, Totrov MM, Kuznetsov DN: ICM - a new method for protein modelling and design applications to docking and structure prediction from the distorted native conformation. J. Comp. Chem. 1994, 15:488-506